DNMT3A and acute myeloid leukemia: To achieve this, we performed enrichment analysis of 332 ENCODE‐derived TFs at differentially methylated CpGs (DMCs) in AML patients with DNMT3A or IDH2 mutations, analyzing each mutation subgroup separately.